(R)-3-((S)-3-(1H-Imidazol-4-yl)-2-((S)-5-oxopyrrolidine-2-carboxamido)propanoyl)thiazolidine-4-carboxamide

Catalog No. :
ACTFKQ359
CAS No. :
57817-98-8
Molecular Formula :
C15H20N6O4S
Molecular Weight :
380.43

IUPAC Name:(R)-3-(((S)-5-oxopyrrolidine-2-carbonyl)-L-histidyl)thiazolidine-4-carboxamide

(R)-3-((S)-3-(1H-Imidazol-4-yl)-2-((S)-5-oxopyrrolidine-2-carboxamido)propanoyl)thiazolidine-4-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-3-((S)-3-(1H-Imidazol-4-yl)-2-((S)-5-oxopyrrolidine-2-carboxamido)propanoyl)thiazolidine-4-carboxamide
IUPAC Name(R)-3-(((S)-5-oxopyrrolidine-2-carbonyl)-L-histidyl)thiazolidine-4-carboxamide
Molecular FormulaC15H20N6O4S
Molecular Weight380.43
SMILESO=C([C@H]1N(C([C@H](CC2=CNC=N2)NC([C@H](CC3)NC3=O)=O)=O)CSC1)N
InChI KeyYJNTVNWNMXWUEH-DCAQKATOSA-N
Synonym4-Thiazolidinecarboxamide, 3-[N-(5-oxo-L-prolyl)-L-histidyl]-, (R)- (9CI)
CAS No.57817-98-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTFKQ359 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCSTX691 route compound structure diagram
    ACCSTX69128874-51-3 In Stock
  4. Then
  5. ACTFKQ359 route product structure diagram
    ACTFKQ35957817-98-8
Inquiry

2. ACTFKQ359 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTFKQ359 route product structure diagram
    ACTFKQ35957817-98-8
Inquiry

Comments (0)